Sode, Koji <br/><br/>
Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation.  [electronic resource] 

 -  Biochemical and biophysical research communications  Sep 2005 
 - 432-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-291X 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2005.07.100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--metabolism<br/>Amino Acid Sequence<br/>Amyloid--chemistry<br/>Bone Marrow Cells--cytology<br/>Circular Dichroism<br/>DNA--chemistry<br/>DNA, Complementary--metabolism<br/>Gene Library<br/>Humans<br/>Light<br/>Models, Molecular<br/>Molecular Sequence Data<br/>Mutagenesis, Site-Directed<br/>Mutation<br/>Nerve Tissue Proteins--chemistry<br/>Parkinson Disease--metabolism<br/>Peptides--chemistry<br/>Polymerase Chain Reaction<br/>Proline--chemistry<br/>Protein Binding<br/>Protein Conformation<br/>Protein Engineering<br/>Protein Structure, Secondary<br/>Scattering, Radiation<br/>Synucleins<br/>Time Factors<br/>Ubiquitin-Protein Ligases--chemistry<br/>Ultraviolet Rays<br/>Valine--chemistry<br/>alpha-Synuclein